Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1024/1661-8157/a001907 | DOI Listing |
Rep Biochem Mol Biol
April 2021
Department of Microbiology, Faculty of Basic Science, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.
Background: This study aims to specify the antimicrobial resistance pattern and virulence genes of isolated from urinary tract infections in Shahrekord, Iran.
Methods: Urine samples of 1000 people suspected of having urinary tract infections referred to Shahrekord medical diagnostic laboratories were examined. Biofilm assays were performed by microtiter plate test through reading the OD490.
Microb Drug Resist
December 2020
Key Laboratory of Quality and Safety Risk Assessment for Aquatic Products on Storage and Preservation (Shanghai), China Ministry of Agriculture, College of Food Science and Technology, Shanghai Ocean University, Shanghai, People's Republic of China.
is a waterborne bacterium and can cause epidemic cholera disease worldwide. Continuous monitoring of contamination in aquatic products is imperative for assuring food safety. In this study, we determined virulence, antimicrobial susceptibility, heavy metal tolerance, and genomic fingerprints of 370 isolates recovered from 12 species of commonly consumed aquatic products collected from July to September of 2018 in Shanghai, China.
View Article and Find Full Text PDFJ Pathog
February 2016
Biotechnology Division, Defence Research & Development Establishment, Jhansi Road, Gwalior 474002, India.
In September 2010, a cholera outbreak was reported from Odisha, Eastern India. V. cholerae isolated from the clinical samples were biochemically and serologically confirmed as serogroup O1, biotype El Tor, and serotype Ogawa.
View Article and Find Full Text PDFHosp Pharm
March 2015
Chair and Clinical Professor, Department of Pharmacy Practice, Temple University School of Pharmacy , Philadelphia, Pennsylvania ; Clinical Advisor, Institute for Safe Medication Practices, Horsham, Pennsylvania.
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers. Write to Dr.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!